Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Carcinoma, Hepatocellular | 5 | 2019 | 1222 | 1.20 | Why? |
| Liver Neoplasms | 5 | 2019 | 1666 | 1.05 | Why? |
| Radiation Pneumonitis | 1 | 2020 | 28 | 0.87 | Why? |
| Biomimetics | 1 | 2021 | 84 | 0.86 | Why? |
| Nanoparticles | 3 | 2021 | 2040 | 0.83 | Why? |
| Hepatocyte Nuclear Factor 3-beta | 1 | 2019 | 6 | 0.82 | Why? |
| Hepatocyte Nuclear Factor 4 | 1 | 2019 | 38 | 0.79 | Why? |
| Gastroscopy | 1 | 2020 | 112 | 0.78 | Why? |
| Plant Proteins | 3 | 2018 | 194 | 0.75 | Why? |
| Glycyrrhizic Acid | 1 | 2021 | 190 | 0.75 | Why? |
| Receptors, Leukotriene | 1 | 2018 | 13 | 0.74 | Why? |
| Silicon Dioxide | 1 | 2019 | 131 | 0.74 | Why? |
| Neoplastic Stem Cells | 1 | 2019 | 120 | 0.72 | Why? |
| Drug Carriers | 2 | 2021 | 590 | 0.70 | Why? |
| Zea mays | 1 | 2017 | 24 | 0.69 | Why? |
| Mycotoxins | 1 | 2017 | 19 | 0.68 | Why? |
| Edible Grain | 1 | 2017 | 26 | 0.68 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2019 | 242 | 0.64 | Why? |
| Oryza | 1 | 2017 | 86 | 0.62 | Why? |
| Hepatocytes | 1 | 2019 | 549 | 0.60 | Why? |
| Food Contamination | 1 | 2017 | 142 | 0.60 | Why? |
| Janus Kinase 1 | 1 | 2017 | 254 | 0.58 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2020 | 669 | 0.54 | Why? |
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 1014 | 0.53 | Why? |
| Anti-Inflammatory Agents | 3 | 2021 | 6153 | 0.51 | Why? |
| Fungi | 1 | 2017 | 471 | 0.51 | Why? |
| Cell Differentiation | 1 | 2019 | 1338 | 0.49 | Why? |
| Metal Nanoparticles | 1 | 2019 | 771 | 0.46 | Why? |
| Gastrointestinal Tract | 1 | 2020 | 1113 | 0.45 | Why? |
| Cerebral Hemorrhage | 1 | 2019 | 820 | 0.44 | Why? |
| Mice, Nude | 3 | 2019 | 340 | 0.40 | Why? |
| Antineoplastic Agents | 3 | 2019 | 3550 | 0.37 | Why? |
| Mice, Inbred BALB C | 7 | 2021 | 5814 | 0.37 | Why? |
| CRISPR-Cas Systems | 1 | 2018 | 1397 | 0.37 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.36 | Why? |
| Signal Transduction | 4 | 2019 | 7207 | 0.36 | Why? |
| Arsenic | 2 | 2019 | 85 | 0.36 | Why? |
| Cell Proliferation | 4 | 2019 | 1973 | 0.35 | Why? |
| MicroRNAs | 2 | 2017 | 1787 | 0.33 | Why? |
| Proteomics | 1 | 2018 | 2481 | 0.32 | Why? |
| STAT3 Transcription Factor | 2 | 2019 | 268 | 0.31 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.30 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.29 | Why? |
| Tomography, X-Ray Computed | 8 | 2020 | 25144 | 0.27 | Why? |
| Virus Diseases | 1 | 2021 | 3779 | 0.26 | Why? |
| Drugs, Chinese Herbal | 1 | 2019 | 2760 | 0.25 | Why? |
| Coronavirus Infections | 18 | 2020 | 253789 | 0.25 | Why? |
| Arsenites | 2 | 2019 | 15 | 0.25 | Why? |
| Pneumonia, Viral | 18 | 2020 | 243684 | 0.23 | Why? |
| Betacoronavirus | 17 | 2020 | 204454 | 0.23 | Why? |
| Cell Line, Tumor | 6 | 2019 | 3608 | 0.22 | Why? |
| Viscosity | 2 | 2018 | 47 | 0.22 | Why? |
| RAW 264.7 Cells | 1 | 2021 | 316 | 0.21 | Why? |
| Nasopharyngeal Neoplasms | 1 | 2020 | 64 | 0.21 | Why? |
| Manganese Compounds | 1 | 2019 | 13 | 0.21 | Why? |
| THP-1 Cells | 1 | 2021 | 374 | 0.20 | Why? |
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2019 | 7 | 0.20 | Why? |
| Cell Shape | 1 | 2019 | 57 | 0.20 | Why? |
| Magnetite Nanoparticles | 2 | 2019 | 109 | 0.20 | Why? |
| Hydrogen-Ion Concentration | 3 | 2019 | 993 | 0.20 | Why? |
| Apoptosis | 3 | 2019 | 2335 | 0.20 | Why? |
| Respiratory Muscles | 1 | 2020 | 116 | 0.19 | Why? |
| Oxygenases | 1 | 2018 | 6 | 0.19 | Why? |
| Medicago truncatula | 1 | 2018 | 3 | 0.19 | Why? |
| Neoplasm Grading | 2 | 2017 | 400 | 0.19 | Why? |
| Oxides | 1 | 2019 | 77 | 0.19 | Why? |
| Dopamine | 1 | 2019 | 123 | 0.19 | Why? |
| Lung | 7 | 2021 | 31049 | 0.19 | Why? |
| Elastic Modulus | 1 | 2018 | 22 | 0.19 | Why? |
| Environmental Restoration and Remediation | 1 | 2018 | 22 | 0.18 | Why? |
| Antibiotics, Antineoplastic | 1 | 2019 | 128 | 0.18 | Why? |
| Mammary Neoplasms, Experimental | 1 | 2018 | 21 | 0.18 | Why? |
| Nanocomposites | 1 | 2018 | 62 | 0.18 | Why? |
| Soil Microbiology | 1 | 2018 | 63 | 0.18 | Why? |
| Soil Pollutants | 1 | 2018 | 57 | 0.18 | Why? |
| Fumonisins | 1 | 2017 | 2 | 0.18 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.17 | Why? |
| Ochratoxins | 1 | 2017 | 4 | 0.17 | Why? |
| Clathrin Heavy Chains | 1 | 2017 | 5 | 0.17 | Why? |
| Aflatoxins | 1 | 2017 | 7 | 0.17 | Why? |
| Elasticity | 1 | 2017 | 70 | 0.17 | Why? |
| Tissue Distribution | 1 | 2019 | 483 | 0.17 | Why? |
| Genes, Tumor Suppressor | 1 | 2017 | 43 | 0.17 | Why? |
| Cisplatin | 1 | 2018 | 209 | 0.17 | Why? |
| Delayed-Action Preparations | 1 | 2019 | 291 | 0.17 | Why? |
| Cytochrome P-450 Enzyme System | 1 | 2018 | 144 | 0.17 | Why? |
| Ferric Compounds | 1 | 2018 | 136 | 0.17 | Why? |
| Vimentin | 1 | 2017 | 86 | 0.17 | Why? |
| Janus Kinase 2 | 1 | 2019 | 218 | 0.17 | Why? |
| Gels | 1 | 2017 | 111 | 0.17 | Why? |
| Doxorubicin | 1 | 2019 | 313 | 0.16 | Why? |
| Neoplasm Invasiveness | 1 | 2019 | 582 | 0.16 | Why? |
| Seeds | 1 | 2017 | 114 | 0.16 | Why? |
| Coronavirus | 3 | 2020 | 18339 | 0.16 | Why? |
| Inhibitory Concentration 50 | 1 | 2019 | 907 | 0.16 | Why? |
| Transfection | 1 | 2019 | 864 | 0.16 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.15 | Why? |
| Apoptosis Regulatory Proteins | 1 | 2017 | 202 | 0.15 | Why? |
| Hep G2 Cells | 1 | 2017 | 391 | 0.15 | Why? |
| Stroke | 1 | 2019 | 8839 | 0.15 | Why? |
| Sodium Chloride | 1 | 2017 | 203 | 0.15 | Why? |
| Esophageal Neoplasms | 1 | 2020 | 357 | 0.15 | Why? |
| Materials Testing | 1 | 2018 | 380 | 0.14 | Why? |
| Carcinogenesis | 1 | 2017 | 236 | 0.14 | Why? |
| Complement Activation | 1 | 2021 | 949 | 0.14 | Why? |
| Magnetic Resonance Imaging | 3 | 2017 | 6551 | 0.14 | Why? |
| RNA Interference | 1 | 2017 | 534 | 0.13 | Why? |
| Humans | 35 | 2021 | 930598 | 0.13 | Why? |
| Animals | 10 | 2021 | 78931 | 0.13 | Why? |
| Phosphoproteins | 2 | 2021 | 4346 | 0.13 | Why? |
| Gene Expression Profiling | 2 | 2018 | 3788 | 0.13 | Why? |
| Cell Movement | 1 | 2017 | 695 | 0.13 | Why? |
| Neoplasms | 3 | 2020 | 17251 | 0.13 | Why? |
| Multimodal Imaging | 1 | 2017 | 534 | 0.13 | Why? |
| Aspartate Aminotransferases | 1 | 2020 | 1394 | 0.12 | Why? |
| Lung Neoplasms | 2 | 2020 | 3228 | 0.12 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.12 | Why? |
| Chrysanthemum | 1 | 2011 | 3 | 0.12 | Why? |
| Mice | 4 | 2021 | 21357 | 0.12 | Why? |
| RNA, Small Interfering | 1 | 2017 | 817 | 0.12 | Why? |
| Genes, Plant | 1 | 2011 | 42 | 0.12 | Why? |
| Murine hepatitis virus | 1 | 2021 | 1720 | 0.12 | Why? |
| Zinc | 1 | 2019 | 817 | 0.11 | Why? |
| Adult | 16 | 2021 | 244371 | 0.11 | Why? |
| Middle Aged | 17 | 2021 | 270681 | 0.11 | Why? |
| Antioxidants | 1 | 2021 | 1593 | 0.11 | Why? |
| Up-Regulation | 1 | 2019 | 2249 | 0.11 | Why? |
| Down-Regulation | 1 | 2017 | 1416 | 0.11 | Why? |
| Nitric Oxide | 1 | 2018 | 769 | 0.11 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.11 | Why? |
| Ferrosoferric Oxide | 1 | 2010 | 19 | 0.10 | Why? |
| Female | 21 | 2021 | 380317 | 0.10 | Why? |
| Male | 21 | 2021 | 367725 | 0.10 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.10 | Why? |
| Pandemics | 17 | 2020 | 389249 | 0.10 | Why? |
| Thorax | 1 | 2020 | 1873 | 0.10 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.10 | Why? |
| Dyspnea | 2 | 2020 | 3847 | 0.10 | Why? |
| Retrospective Studies | 9 | 2021 | 105322 | 0.10 | Why? |
| Methylprednisolone | 1 | 2020 | 2107 | 0.10 | Why? |
| Hot Temperature | 1 | 2017 | 1299 | 0.09 | Why? |
| Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.09 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.09 | Why? |
| Gastrointestinal Microbiome | 1 | 2021 | 1961 | 0.09 | Why? |
| China | 9 | 2021 | 50654 | 0.09 | Why? |
| Aged | 14 | 2021 | 215776 | 0.09 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2020 | 11367 | 0.08 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.08 | Why? |
| Stress, Physiological | 1 | 2011 | 378 | 0.08 | Why? |
| Ultrasonography | 2 | 2020 | 4409 | 0.08 | Why? |
| Disease Progression | 3 | 2021 | 13580 | 0.08 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.08 | Why? |
| Liver | 1 | 2021 | 4007 | 0.08 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2020 | 12361 | 0.08 | Why? |
| Biomarkers | 2 | 2020 | 23361 | 0.08 | Why? |
| Lung Diseases | 1 | 2020 | 2361 | 0.08 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.07 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Cell Line | 1 | 2019 | 12040 | 0.06 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.06 | Why? |
| Hypertension | 2 | 2021 | 8895 | 0.06 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.05 | Why? |
| Allosteric Regulation | 1 | 2021 | 134 | 0.05 | Why? |
| Prognosis | 5 | 2021 | 32490 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2019 | 10649 | 0.05 | Why? |
| Virus Replication | 1 | 2021 | 14331 | 0.05 | Why? |
| Convalescence | 2 | 2021 | 2829 | 0.05 | Why? |
| Ipomoea | 1 | 2018 | 2 | 0.05 | Why? |
| Plant Shoots | 1 | 2018 | 3 | 0.05 | Why? |
| Prothrombin Time | 1 | 2021 | 434 | 0.05 | Why? |
| Porosity | 1 | 2019 | 185 | 0.05 | Why? |
| Antigen-Antibody Complex | 1 | 2021 | 408 | 0.05 | Why? |
| Trichoderma | 1 | 2018 | 7 | 0.05 | Why? |
| Drug Liberation | 1 | 2019 | 141 | 0.05 | Why? |
| Interleukin-6 | 1 | 2017 | 7522 | 0.05 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.05 | Why? |
| Vital Capacity | 1 | 2020 | 399 | 0.05 | Why? |
| Enzymes | 1 | 2018 | 67 | 0.05 | Why? |
| Povidone | 1 | 2017 | 21 | 0.05 | Why? |
| Phosphorus | 1 | 2018 | 80 | 0.04 | Why? |
| Mesenchymal Stem Cell Transplantation | 1 | 2010 | 1322 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.04 | Why? |
| Cardiovascular Diseases | 2 | 2020 | 11497 | 0.04 | Why? |
| Plant Roots | 1 | 2018 | 108 | 0.04 | Why? |
| Liver Cirrhosis | 1 | 2010 | 1810 | 0.04 | Why? |
| RNA, Ribosomal, 16S | 1 | 2021 | 793 | 0.04 | Why? |
| Stress, Mechanical | 1 | 2018 | 143 | 0.04 | Why? |
| Nitrogen | 1 | 2018 | 106 | 0.04 | Why? |
| Neoplasm Transplantation | 1 | 2017 | 55 | 0.04 | Why? |
| Muscle Strength | 1 | 2020 | 317 | 0.04 | Why? |
| Soil | 1 | 2018 | 137 | 0.04 | Why? |
| Gallic Acid | 1 | 2017 | 49 | 0.04 | Why? |
| Forced Expiratory Volume | 1 | 2020 | 632 | 0.04 | Why? |
| Half-Life | 1 | 2017 | 298 | 0.04 | Why? |
| Chi-Square Distribution | 1 | 2020 | 961 | 0.04 | Why? |
| Spirometry | 1 | 2020 | 524 | 0.04 | Why? |
| Feces | 2 | 2021 | 4235 | 0.04 | Why? |
| Fatty Acids | 1 | 2018 | 238 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.04 | Why? |
| DNA Damage | 1 | 2018 | 285 | 0.04 | Why? |
| Extracellular Matrix | 1 | 2018 | 189 | 0.04 | Why? |
| Mouth | 1 | 2021 | 622 | 0.04 | Why? |
| Carbon | 1 | 2018 | 269 | 0.04 | Why? |
| Antibody Affinity | 1 | 2021 | 1078 | 0.04 | Why? |
| Pharyngitis | 1 | 2020 | 687 | 0.04 | Why? |
| Genes, Reporter | 1 | 2017 | 472 | 0.04 | Why? |
| Luciferases | 1 | 2017 | 378 | 0.04 | Why? |
| Drug Resistance, Neoplasm | 1 | 2018 | 447 | 0.04 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.04 | Why? |
| Geography | 1 | 2020 | 1801 | 0.03 | Why? |
| Exercise Test | 1 | 2020 | 911 | 0.03 | Why? |
| Nomograms | 1 | 2020 | 790 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2021 | 2689 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2020 | 2324 | 0.03 | Why? |
| Radiography, Thoracic | 2 | 2020 | 5486 | 0.03 | Why? |
| Polymers | 1 | 2017 | 507 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2020 | 1755 | 0.03 | Why? |
| Fever | 2 | 2020 | 7795 | 0.03 | Why? |
| Patient Acuity | 1 | 2020 | 1755 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| Cohort Studies | 3 | 2020 | 36005 | 0.03 | Why? |
| Risk Assessment | 3 | 2021 | 25439 | 0.03 | Why? |
| Cell Survival | 1 | 2017 | 1581 | 0.03 | Why? |
| Dextrans | 1 | 2010 | 35 | 0.03 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.03 | Why? |
| Bacteria | 1 | 2021 | 1897 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Protein Conformation | 1 | 2021 | 4386 | 0.03 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.02 | Why? |
| Neoplasm Staging | 1 | 2017 | 1999 | 0.02 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.02 | Why? |
| Fatigue | 1 | 2020 | 2479 | 0.02 | Why? |
| Staining and Labeling | 1 | 2010 | 169 | 0.02 | Why? |
| ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
| Epitopes | 1 | 2021 | 4113 | 0.02 | Why? |
| Peptides | 1 | 2021 | 2513 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2020 | 48226 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2018 | 3786 | 0.02 | Why? |
| Infant | 2 | 2021 | 30274 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| Oxygen | 1 | 2021 | 3715 | 0.02 | Why? |
| Reference Standards | 1 | 2011 | 1163 | 0.02 | Why? |
| Child | 3 | 2021 | 70012 | 0.02 | Why? |
| Point-of-Care Testing | 1 | 2020 | 2782 | 0.02 | Why? |
| Rats, Sprague-Dawley | 1 | 2010 | 987 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| Cough | 1 | 2020 | 4891 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Transcriptome | 1 | 2018 | 3466 | 0.02 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.02 | Why? |
| Artificial Intelligence | 1 | 2020 | 3543 | 0.02 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
| Patient Discharge | 1 | 2020 | 5696 | 0.02 | Why? |
| Contrast Media | 1 | 2010 | 1011 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.02 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.02 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.01 | Why? |
| Rats | 1 | 2010 | 2764 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Cells, Cultured | 1 | 2010 | 5835 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |